UK markets closed

Saniona AB (publ) (SANION.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
1.7780+0.0020 (+0.11%)
At close: 05:23PM CEST

Saniona AB (publ)

Smedeland 26B
Glostrup 2600
Denmark
45 70 70 52 25
https://www.saniona.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees23

Key executives

NameTitlePayExercisedYear born
Mr. Jorgen Drejer Ph.D.Founder, Chairman & Deputy CEO3.28MN/A1955
Mr. Thomas Feldthus M.Sc., MBACo-Founder & CEO2.32MN/A1960
Ms. Anita Milland B.Com.Chief Financial OfficerN/AN/A1968
Mr. Karin Sandager Nielsen Ph.D.Chief Scientific OfficerN/AN/A1970
Mr. Palle Christophersen M.S., Ph.D.Executive Vice President of Research1.38MN/A1958
Mr. Janus Schreiber LarsenChief Development OfficerN/AN/A1972
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Saniona AB (publ), a biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Denmark. It also develops medicines modulating ion channels. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which has completed Phase 1 clinical stage for neuropathic pain conditions; SAN903 for inflammatory and fibrotic disorders; and SAN2219, that is in preclinical stage for treatment of epilepsy. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS; and research collaboration with AstronauTx to identify new treatments for Alzheimer's disease. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.

Corporate governance

Saniona AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.